Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progression
about
FOXD3 regulates migration properties and Rnd3 expression in melanoma cellsFOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.The history and future of targeting cyclin-dependent kinases in cancer therapy.Downregulation of Noxa by RAF/MEK inhibition counteracts cell death response in mutant B-RAF melanoma cells.Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3Understanding signaling cascades in melanomaGrowth factors and oncogenes as targets in melanoma: lost in translation?In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitors.Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.Upcoming strategies for the treatment of metastatic melanoma.Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma.Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.Treatment of cutaneous melanoma: current approaches and future prospects.Cyclin D1 and D3 expression in melanocytic skin lesions.Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors.Targeting CDK6 and BCL2 exploits the "MYB addiction" of Ph+ acute lymphoblastic leukemia.Activated platelet-derived growth factor beta receptor expression, PI3K-AKT pathway molecular analysis, and transforming signals in equine sarcoids.Role of cyclins D1 and D3 in vestibular schwannoma.
P2860
Q24633339-D109D017-D5C6-4F6C-9B97-6E4BBEAC747BQ33767083-97D1D307-110F-4312-BFC0-8658C2136E0BQ34460347-BE1C7E0A-5280-4534-B5A0-E6BF0962E5EFQ36439920-927B163B-D958-4D7C-846D-23F299A87A4EQ36793441-B288091E-53FB-4EF3-8D66-73EF08DFD030Q37034487-77B6157D-778A-4062-A9C2-74F6813F737DQ37045217-170C5B6A-980E-4EAE-BDAC-9BF593E9D68AQ37365693-0E24D350-3273-4D55-93B4-F8F4E7449D81Q37605787-CCCE6D84-80ED-4622-AA6E-101E4427F8ADQ37986477-53B7494B-2893-4386-81E0-65E5B80F4D3EQ38913787-2B54101C-0E0A-4AD7-8189-1D3D305455C6Q39656465-3DA7F41E-CF39-461B-804F-8C69946E7996Q39801051-EBFED93E-C01F-4951-808D-D44F846287DFQ41779381-11544636-F4C2-4E77-91FB-1DF2A5A90E10Q47321072-DA429B6A-32E0-47DD-9FAA-006D90716122Q48571436-4084929A-C2D5-4695-929B-D55FEF79D9EAQ51774818-8EB9DB5E-E388-4DEC-B165-B2401F068E90Q52931721-2738E044-EE92-411F-AF38-4FCB63EC34CC
P2860
Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progression
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@ast
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@en
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@nl
type
label
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@ast
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@en
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@nl
prefLabel
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@ast
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@en
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@nl
P2093
P2860
P356
P1476
Cyclin D3 expression in melano ...... ontributes to G1-S progression
@en
P2093
Andrew E Aplin
Ethan V Abel
Karen Boisvert-Adamo
Laurie S Spofford
P2860
P304
25644-25651
P356
10.1074/JBC.M600197200
P407
P577
2006-06-29T00:00:00Z